Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan
· Delayed Price · Currency is TWD 66.60
-0.90 (-1.33%)
Apr 2, 2025, 1:30 PM CST
Easywell Biomedicals Revenue
In the year 2024, Easywell Biomedicals had annual revenue of 540.44M TWD with 98.96% growth. Easywell Biomedicals had revenue of 153.67M in the quarter ending December 31, 2024, with 58.36% growth.
Revenue
540.44M
Revenue Growth
+98.96%
P/S Ratio
14.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 540.44M | 268.81M | 98.96% |
| Dec 31, 2023 | 271.63M | 92.73M | 51.83% |
| Dec 31, 2022 | 178.90M | -18.38M | -9.32% |
| Dec 31, 2021 | 197.28M | -70.38M | -26.29% |
| Dec 31, 2020 | 267.65M | -92.31M | -25.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |